The instruction for medical use
of ALERGOZOL-DF® medicine
the Trade name
of Alergozol-DF®
the International unlicensed name
Is not present
the Dosage form
Spray of nasal 0.03% and 0.06% 10 ml
Structure
10.0 ml of drug contain 0.03% 0.06%
active agents: Naphthyzinum 3.0 mg 6.0 mg
a difengidramina a hydrochloride of 5.0 mg 10.0 mg
excipients – boric acid, the water purified
the Description
Transparent colourless or slightly yellowish color liquid.
Pharmacotherapeutic group
of Antikongestanta and other nasal drugs for topical administration. Naphazoline in a combination with other drugs.
The code of automatic telephone exchange R01AB02
the Pharmacological
Alergozola-DF® Pharmacokinetics Therapeutic Effect properties develops in 5-10 min. after use of drug and proceeds up to 5-6 h, at frequent use of drug duration of action can be reduced to 4 h. Active agents of the drug Alergozol-DF® at topical administration can be soaked up in a system blood stream and have resorptive effect.
A pharmacodynamics
of Alergozol-DF® - the combined drug for topical administration containing Naphthyzinum and Dimedrol. Has antiallergic and vasoconstrictive effect.
Naphthyzinum at intranasal use promotes simplification of nasal breath in rhinitises. Promotes opening and expansion of output channels of adnexal bosoms of a nose and release of Eustachian tubes. It promotes outflow of a secret and prevents sedimentation of bacteria on mucous a nose.
Dimedrol - a blocker of N1-of histamine receptors. Has the significant antihistaminic activity. Reduces or warns spasms of smooth muscles, the increase in permeability of capillaries, hypostasis of fabrics, naggers and hyperaemia caused by a histamine. Also has mestnoanesteziruyushchy effect, relaxes smooth muscles as a result of direct spasmolytic influence, blocks holinoretseptor of vegetative ganglia in moderate degree.
Indications
- acute rhinitis
- allergic rinosinusit
- allergic vasomotorial rhinitis
- hyperaemia and puffiness of mucous membranes of upper airways after operations
- simplification of carrying out a rinoskopiya
the Route of administration and doses
of Adult 0.06% on the 1st injection of spray in each nasal course 3 times a day.
For children:
- from 2 to 6 years of 0.03% – on the 1st injection of spray in each nasal course 1-2 times a day,
- from 6 to 15 years of 0.03% – on the 1st injection of spray in each nasal course 3 times a day.
Course of treatment no more than 1 week.
Side effects
- a headache
- increase in arterial blood pressure, tachycardia
- irritation of a mucous membrane
- nausea, a headache
- a reactive hyperemia of a mucous membrane
- dryness in a mouth
- at use more than 1 week – hypostasis of a mucous membrane, atrophic rhinitis
of the Contraindication
- hypersensitivity to drug components
- closed-angle glaucoma
- a serious illness of eyes
- an arterial hypertension, tachycardia, the profound atherosclerosis
- a hyper thyroidism
- diabetes
- chronic rhinitis
- a prostatauxe
- a concomitant use of inhibitors of a monoaminooxidase and the period up to 14 days after the end of their use
- children's age up to 2 years
Medicinal interactions
Drug slows down absorption of mestnoanesteziruyushchy means (extends their action when carrying out surface anesthesia).
It is incompatible with monoaminooxidase inhibitors.
The special
instructions Drug has resorptive effect in this connection it is necessary to apply it quickly – no more than 1 week, then to take a break for several days.
Pregnancy and lactation
Use of drug at pregnancy and in the period of a lactation perhaps only when the expected advantage for mother exceeds potential risk for the child and a fruit.
Features of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms
Considering side effects of drug it is necessary to be careful at control of motor transport or potentially dangerous mechanisms
Overdose
Symptoms: decrease in body temperature, bradycardia, arterial hypertension, dryness in a mouth, breath difficulty, arousing, confusion of consciousness.
Symptomatic treatment.
A form of release and packing
On 10 ml in polypropylene bottles with a cover the spray and a protective cap. Bottles together with iinstruktion on medical use in the state and Russian languages place in group packing or on one bottle together with the instruction for medical use in the state and Russian languages place in a pack cardboard.
To Store storage conditions in the place protected from light, at a temperature not above 25 °C.
To store out of children's reach!
3 years
not to apply a period of storage after an expiration date.
Prescription status
Without prescription
DOSFARM LLP Producer, Republic of Kazakhstan, Almaty, Chaplygin St., 3.
The address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products
of DOSFARM LLP, Republic of Kazakhstan, Almaty, Chaplygin St., 3, ph./fax: (727) 253-03-88, el. address: dospharm@dospharm.kz
of ALERGOZOL-DF® medicine
the Trade name
of Alergozol-DF®
the International unlicensed name
Is not present
the Dosage form
Spray of nasal 0.03% and 0.06% 10 ml
Structure
10.0 ml of drug contain 0.03% 0.06%
active agents: Naphthyzinum 3.0 mg 6.0 mg
a difengidramina a hydrochloride of 5.0 mg 10.0 mg
excipients – boric acid, the water purified
the Description
Transparent colourless or slightly yellowish color liquid.
Pharmacotherapeutic group
of Antikongestanta and other nasal drugs for topical administration. Naphazoline in a combination with other drugs.
The code of automatic telephone exchange R01AB02
the Pharmacological
Alergozola-DF® Pharmacokinetics Therapeutic Effect properties develops in 5-10 min. after use of drug and proceeds up to 5-6 h, at frequent use of drug duration of action can be reduced to 4 h. Active agents of the drug Alergozol-DF® at topical administration can be soaked up in a system blood stream and have resorptive effect.
A pharmacodynamics
of Alergozol-DF® - the combined drug for topical administration containing Naphthyzinum and Dimedrol. Has antiallergic and vasoconstrictive effect.
Naphthyzinum at intranasal use promotes simplification of nasal breath in rhinitises. Promotes opening and expansion of output channels of adnexal bosoms of a nose and release of Eustachian tubes. It promotes outflow of a secret and prevents sedimentation of bacteria on mucous a nose.
Dimedrol - a blocker of N1-of histamine receptors. Has the significant antihistaminic activity. Reduces or warns spasms of smooth muscles, the increase in permeability of capillaries, hypostasis of fabrics, naggers and hyperaemia caused by a histamine. Also has mestnoanesteziruyushchy effect, relaxes smooth muscles as a result of direct spasmolytic influence, blocks holinoretseptor of vegetative ganglia in moderate degree.
Indications
- acute rhinitis
- allergic rinosinusit
- allergic vasomotorial rhinitis
- hyperaemia and puffiness of mucous membranes of upper airways after operations
- simplification of carrying out a rinoskopiya
the Route of administration and doses
of Adult 0.06% on the 1st injection of spray in each nasal course 3 times a day.
For children:
- from 2 to 6 years of 0.03% – on the 1st injection of spray in each nasal course 1-2 times a day,
- from 6 to 15 years of 0.03% – on the 1st injection of spray in each nasal course 3 times a day.
Course of treatment no more than 1 week.
Side effects
- a headache
- increase in arterial blood pressure, tachycardia
- irritation of a mucous membrane
- nausea, a headache
- a reactive hyperemia of a mucous membrane
- dryness in a mouth
- at use more than 1 week – hypostasis of a mucous membrane, atrophic rhinitis
of the Contraindication
- hypersensitivity to drug components
- closed-angle glaucoma
- a serious illness of eyes
- an arterial hypertension, tachycardia, the profound atherosclerosis
- a hyper thyroidism
- diabetes
- chronic rhinitis
- a prostatauxe
- a concomitant use of inhibitors of a monoaminooxidase and the period up to 14 days after the end of their use
- children's age up to 2 years
Medicinal interactions
Drug slows down absorption of mestnoanesteziruyushchy means (extends their action when carrying out surface anesthesia).
It is incompatible with monoaminooxidase inhibitors.
The special
instructions Drug has resorptive effect in this connection it is necessary to apply it quickly – no more than 1 week, then to take a break for several days.
Pregnancy and lactation
Use of drug at pregnancy and in the period of a lactation perhaps only when the expected advantage for mother exceeds potential risk for the child and a fruit.
Features of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms
Considering side effects of drug it is necessary to be careful at control of motor transport or potentially dangerous mechanisms
Overdose
Symptoms: decrease in body temperature, bradycardia, arterial hypertension, dryness in a mouth, breath difficulty, arousing, confusion of consciousness.
Symptomatic treatment.
A form of release and packing
On 10 ml in polypropylene bottles with a cover the spray and a protective cap. Bottles together with iinstruktion on medical use in the state and Russian languages place in group packing or on one bottle together with the instruction for medical use in the state and Russian languages place in a pack cardboard.
To Store storage conditions in the place protected from light, at a temperature not above 25 °C.
To store out of children's reach!
3 years
not to apply a period of storage after an expiration date.
Prescription status
Without prescription
DOSFARM LLP Producer, Republic of Kazakhstan, Almaty, Chaplygin St., 3.
The address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products
of DOSFARM LLP, Republic of Kazakhstan, Almaty, Chaplygin St., 3, ph./fax: (727) 253-03-88, el. address: dospharm@dospharm.kz
Related Products
